A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
Clinical trial NCT05084963 · COMPLETED
Trial details
- NCT number
- NCT05084963
- Sponsor
- Revolo Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-29
- Primary completion
- 2022-10-24
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.